- Home
- CEP vs LXEO Comparison
CEP vs LXEO Comparison
Compare CEP & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEP
- LXEO
- Stock Information
- Founded
- CEP 2020
- LXEO 2017
- Country
- CEP United States
- LXEO United States
- Employees
- CEP N/A
- LXEO 72
- Industry
- CEP
- LXEO
- Sector
- CEP
- LXEO
- Exchange
- CEP NYSE
- LXEO Nasdaq
- Market Cap
- CEP 131.6M
- LXEO 154.0M
- IPO Year
- CEP 2024
- LXEO 2023
- Fundamental
- Price
- CEP $31.51
- LXEO $2.69
- Analyst Decision
- CEP
- LXEO Strong Buy
- Analyst Count
- CEP 0
- LXEO 5
- Target Price
- CEP N/A
- LXEO $22.20
- AVG Volume (30 Days)
- CEP 8.6M
- LXEO 892.8K
- Earning Date
- CEP 01-01-0001
- LXEO 05-20-2025
- Dividend Yield
- CEP N/A
- LXEO N/A
- EPS Growth
- CEP N/A
- LXEO N/A
- EPS
- CEP 0.24
- LXEO N/A
- Revenue
- CEP N/A
- LXEO N/A
- Revenue This Year
- CEP N/A
- LXEO N/A
- Revenue Next Year
- CEP N/A
- LXEO N/A
- P/E Ratio
- CEP $142.97
- LXEO N/A
- Revenue Growth
- CEP N/A
- LXEO N/A
- 52 Week Low
- CEP $9.99
- LXEO $1.45
- 52 Week High
- CEP $59.75
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- CEP N/A
- LXEO 41.96
- Support Level
- CEP N/A
- LXEO $2.77
- Resistance Level
- CEP N/A
- LXEO $3.35
- Average True Range (ATR)
- CEP 0.00
- LXEO 0.62
- MACD
- CEP 0.00
- LXEO -0.09
- Stochastic Oscillator
- CEP 0.00
- LXEO 0.69
About CEP CANTOR EQUITY PARTNERS INC
Cantor Equity Partners Inc is a blank check company.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.